It was because they were marketing it as a primary detection device which I believe the FDA said the finding in the study they did meet that. They just recontacted the FDA and will perform another 9 month trial to give them the data that was told to them by the FDA they needed to meet their standards. That was in May.
News 
Market Data 
Discover 
